Crossmark

High-dose rituximab in combination with autologous stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma

Crossref DOI link: https://doi.org/10.1016/j.medcle.2019.11.013

Published Print: 2020-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Shi, Yi-Fen

Zhou, Shu-Juan

Sun, Lan

Yu, Kang

Chen, Yi
License Information

Text and Data Mining valid from 2020-09-01
More Information

This article is maintained by: Elsevier

Article Title: High-dose rituximab in combination with autologous stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2019.11.013

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2019.11.009

Content Type: article

Copyright: © 2019 Elsevier España, S.L.U. All rights reserved.